Back to RENAISSANCE TECHNOLOGIES LLC RENAISSANCE TECHNOLOGIES LLC

PCRXPCRX
27 quarters

Position history for RENAISSANCE TECHNOLOGIES LLCRENAISSANCE TECHNOLOGIES LLC's holdings in PACIRA BIOSCIENCES INC

RENAISSANCE TECHNOLOGIES LLC holds 1.7M shares of PCRX (PACIRA BIOSCIENCES INC), worth $44M as of 2026-Q2. The position was decreased (-5.0% shares). PCRX represents 0.1% of RENAISSANCE TECHNOLOGIES LLC's portfolio.

Current Value

$44M

Current Shares

1.7M

Total Value Change

-$37.4M

Total Shares Change

-63,537

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.7M
-5.0%
$44M0.1%$25.37
0
2026-Q1
Decreased
1.8M
-3.1%
$41.3M0.1%$22.10
0
2025-Q4
Decreased
1.9M
-11.9%
$48.8M0.1%$26.07
0
2025-Q3
Decreased
2.1M
-10.7%
$55.1M0.1%$25.34
0
2025-Q2
Increased
2.4M
+6.9%
$57.3M0.1%$23.48
32
2025-Q1
Increased
2.2M
+12.4%
$55.7M0.1%$24.91
33
2024-Q4
Increased
2M
+0.7%
$37.5M0.1%$18.94
29
2024-Q3
Decreased
2M
-4.2%
$29.8M0.0%$14.54
0
2024-Q2
Increased
2.1M
+9.8%
$59.1M0.1%$28.61
39
2024-Q1
Increased
1.9M
+9.6%
$55M0.1%$29.22
32
2023-Q4
Increased
1.7M
+6.4%
$57.9M0.1%$33.74
31
2023-Q3
Increased
1.6M
+2.5%
$49.5M0.1%$30.68
30
2023-Q2
Increased
1.6M
+1.0%
$63.1M0.1%$39.51
30
2023-Q1
Decreased
1.6M
-1.8%
$63.6M0.1%$40.18
0
2022-Q4
Decreased
1.6M
-9.5%
$61.3M0.1%$38.61
0
2022-Q3
Decreased
1.8M
-10.8%
$93.3M0.1%$54.24
0
2022-Q2
Increased
2M
+5.6%
$114.6M0.1%$58.63
38
2022-Q1
Increased
1.9M
+0.6%
$142M0.2%$75.67
36
2021-Q4
Decreased
1.8M
-6.1%
$111.3M0.1%$60.89
0
2021-Q3
Decreased
2M
-4.4%
$110.3M0.1%$56.72
0
2021-Q2
Decreased
2.1M
-11.0%
$125M0.2%$60.68
0
2021-Q1
Decreased
2.3M
-11.8%
$162.2M0.2%$70.82
0
2020-Q4
Decreased
2.6M
-5.6%
$157.1M0.2%$58.71
0
2020-Q3
Decreased
2.8M
-2.5%
$167.1M0.2%$59.39
0
2020-Q2
Increased
2.9M
+15.5%
$149.6M0.1%$52.02
42
2020-Q1
Increased
2.5M
+37.3%
$82.8M0.1%$33.71
39
2019-Q4
New
1.8M
-
$81.4M0.1%$44.36
41

Other major holders of PCRX: BNP PARIBAS FINANCIAL MARKETS, MACQUARIE GROUP LTD, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used